In a mouse model of CKD, delivery of BMSC-derived exosomes inhibited phosphate-induced aortic calcification and reduced renal fibrosis, and the application of exosomes resulted in reduced urea levels of BUN, Cre, and FGF23 and improved renal function in the CKD model. The gene discussed is FGF23; the disease is chronic kidney disease.